| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 1 175-183, Copyright © 1997 by American Association of Immunologists
ARTICLES |
JJ Bright, LD Kerr and S Sriram
Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Signaling through IL-2R, IL-2 induces tyrosine phosphorylation and activation of Jak-1 and Jak-3 kinases and Stat 3 and Stat 5 transcription factors leading to cell cycle progression of activated T cells from G1 to S phase. TGF-beta is an immunosuppressive cytokine, which inhibits T cell proliferation at G1 to S phase transition. We examined the effect of TGF-beta on IL-2R signal transduction pathway in activated T cells. We show here that treatment of activated T cells with TGF-beta inhibited IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 but not Jak-3 and Stat 3. TGF-beta also inhibited IL-2-induced expression of alpha- and beta-chains of IL-2R and induced apoptotic cell death in T cells. These results suggest that TGF-beta-induced growth arrest and apoptosis are associated with the modulation of IL-2-induced activation of Jak-Stat pathway in T cells.
This article has been cited by other articles:
|
|
 |
|
  A. EISENTHAL, K. EYTAN, E. BRAZOWSKI, G. GITSTEIN, R. GREENBERG, and Y. SKORNICK Effects of 5-FU on DNA Synthesis and Cytotoxicity of Human Lymphocytes Induced by IL-2, TGF-{beta}3 and PGE2 Anticancer Res, October 1, 2009; 29(10): 3925 - 3930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mortarini, C. Vegetti, A. Molla, F. Arienti, F. Ravagnani, A. Maurichi, R. Patuzzo, M. Santinami, and A. Anichini Impaired STAT Phosphorylation in T Cells from Melanoma Patients in Response to IL-2: Association with Clinical Stage Clin. Cancer Res., June 15, 2009; 15(12): 4085 - 4094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Das and A. D. Levine TGF-{beta} Inhibits IL-2 Production and Promotes Cell Cycle Arrest in TCR-Activated Effector/Memory T Cells in the Presence of Sustained TCR Signal Transduction J. Immunol., February 1, 2008; 180(3): 1490 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cocolakis, M. Dai, L. Drevet, J. Ho, E. Haines, S. Ali, and J.-J. Lebrun Smad Signaling Antagonizes STAT5-mediated Gene Transcription and Mammary Epithelial Cell Differentiation J. Biol. Chem., January 18, 2008; 283(3): 1293 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Atreya, C. C Schimanski, C. Becker, S. Wirtz, H. Dornhoff, E. Schnurer, M. R Berger, P. R Galle, W. Herr, and M. F Neurath The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer Gut, November 1, 2007; 56(11): 1572 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Takaki, Y. Minoda, K. Koga, G. Takaesu, A. Yoshimura, and T. Kobayashi TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation. Genes Cells, August 1, 2006; 11(8): 871 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ito, Y. Minamiya, H. Kawai, S. Saito, H. Saito, T. Nakagawa, K. Imai, M. Hirokawa, and J.-i. Ogawa Tumor-Derived TGFbeta-1 Induces Dendritic Cell Apoptosis in the Sentinel Lymph Node J. Immunol., May 1, 2006; 176(9): 5637 - 5643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sela, N. Mauermann, R. Hershkoviz, H. Zinger, M. Dayan, L. Cahalon, J. P. Liu, E. Mozes, and O. Lider The Inhibition of Autoreactive T Cell Functions by a Peptide Based on the CDR1 of an Anti-DNA Autoantibody Is via TGF-{beta}-Mediated Suppression of LFA-1 and CD44 Expression and Function J. Immunol., December 1, 2005; 175(11): 7255 - 7263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-K. Park, L. D. Shultz, J. J. Letterio, and J. D. Gorham TGF-{beta}1 Inhibits T-bet Induction by IFN-{gamma} in Murine CD4+ T Cells through the Protein Tyrosine Phosphatase Src Homology Region 2 Domain-Containing Phosphatase-1 J. Immunol., November 1, 2005; 175(9): 5666 - 5674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shirota, M. Gursel, and D. M. Klinman Suppressive Oligodeoxynucleotides Inhibit Th1 Differentiation by Blocking IFN-{gamma}- and IL-12-Mediated Signaling J. Immunol., October 15, 2004; 173(8): 5002 - 5007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nath, S. Giri, R. Prasad, A. K. Singh, and I. Singh Potential Targets of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor for Multiple Sclerosis Therapy J. Immunol., January 15, 2004; 172(2): 1273 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Hodge, G. L. Hodge, P. N. Reynolds, R. Scicchitano, and M. Holmes Increased production of TGF-{beta} and apoptosis of T lymphocytes isolated from peripheral blood in COPD Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L492 - L499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Nelson, T. P. Martyak, L. J. Thompson, J. J. Moon, and T. Wang Uncoupling of Promitogenic and Antiapoptotic Functions of IL-2 by Smad-Dependent TGF-{beta} Signaling J. Immunol., June 1, 2003; 170(11): 5563 - 5570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mukherjee, P. K. Maiti, and D. Nandi Role of CD80, CD86, and CTLA4 on mouse CD4+ T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin J. Leukoc. Biol., November 1, 2002; 72(5): 921 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Motran, F. L. Diaz, A. Gruppi, D. Slavin, B. Chatton, and J. L. Bocco Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses the accessory cell-dependent T cell proliferation J. Leukoc. Biol., September 1, 2002; 72(3): 512 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Ahmed, A. Mayer, J.-D. Ji, and L. B. Ivashkiv Inhibition of IL-6 signaling by a p38-dependent pathway occurs in the absence of new protein synthesis J. Leukoc. Biol., July 1, 2002; 72(1): 154 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Natarajan and J. J. Bright Curcumin Inhibits Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through Janus Kinase-STAT Pathway in T Lymphocytes J. Immunol., June 15, 2002; 168(12): 6506 - 6513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dennler, M.-J. Goumans, and P. ten Dijke Transforming growth factor {beta} signal transduction J. Leukoc. Biol., May 1, 2002; 71(5): 731 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Bollard, C. Rossig, M. J. Calonge, M. H. Huls, H.-J. Wagner, J. Massague, M. K. Brenner, H. E. Heslop, and C. M. Rooney Adapting a transforming growth factor beta -related tumor protection strategy to enhance antitumor immunity Blood, May 1, 2002; 99(9): 3179 - 3187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Loomis, S. Namiki, D. B. Hoyt, and W. G. Junger Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators Am J Physiol Cell Physiol, September 1, 2001; 281(3): C840 - C848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. M. Campbell, G. Cook, S. E. Robertson, A. Fraser, K. S. Boyd, J. A. Gracie, and I. M. Franklin Suppression of IL-2-Induced T Cell Proliferation and Phosphorylation of STAT3 and STAT5 by Tumor-Derived TGF{{beta}} Is Reversed by IL-15 J. Immunol., July 1, 2001; 167(1): 553 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. V. Whiting, A. M. Williams, M. H. Claesson, S. Bregenholt, J. Reimann, and P. W. Bland Transforming Growth Factor-{beta} Messenger RNA and Protein in Murine Colitis J. Histochem. Cytochem., June 1, 2001; 49(6): 727 - 738. [Abstract] [Full Text]
|
|
|
|
|
|
N. A. Gomes, C. R. Gattass, V. Barreto-de-Souza, M. E. Wilson, and G. A. DosReis TGF-{beta} Mediates CTLA-4 Suppression of Cellular Immunity in Murine Kalaazar J. Immunol., February 15, 2000; 164(4): 2001 - 2008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Grundstrom, M. Dohlsten, and A. Sundstedt IL-2 Unresponsiveness in Anergic CD4+ T Cells Is Due to Defective Signaling Through the Common {gamma}-Chain of the IL-2 Receptor J. Immunol., February 1, 2000; 164(3): 1175 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Araujo and E Bier sog and dpp exert opposing maternal functions to modify toll signaling and pattern the dorsoventral axis of the Drosophila embryo Development, January 8, 2000; 127(16): 3631 - 3644. [Abstract] [PDF]
|
|
|
|
|
|
A.G.S. Buggins, N. Lea, J. Gaken, D. Darling, F. Farzaneh, G.J. Mufti, and W.J.R. Hirst Effect of Costimulation and the Microenvironment on Antigen Presentation by Leukemic Cells Blood, November 15, 1999; 94(10): 3479 - 3490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, I. Scordi, M. J. Smyth, and M. G. Lichtenheld Interleukin 2 Receptor Signaling Regulates the Perforin Gene through Signal Transducer and Activator of Transcription (Stat)5 Activation of Two Enhancers J. Exp. Med., November 1, 1999; 190(9): 1297 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Coccia, N. D. Russo, E. Stellacci, U. Testa, G. Marziali, and A. Battistini STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules Int. Immunol., July 1, 1999; 11(7): 1075 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bright, C. Du, and S. Sriram Tyrphostin B42 Inhibits IL-12-Induced Tyrosine Phosphorylation and Activation of Janus Kinase-2 and Prevents Experimental Allergic Encephalomyelitis J. Immunol., May 15, 1999; 162(10): 6255 - 6262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sudarshan, J. Galon, Y.-j. Zhou, and J. J. O'Shea TGF-{beta} Does Not Inhibit IL-12- and IL-2-Induced Activation of Janus Kinases and STATs J. Immunol., March 1, 1999; 162(5): 2974 - 2981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.G. Begley and N.A. Nicola Resolving Conflicting Signals: Cross Inhibition of Cytokine Signaling Pathways Blood, March 1, 1999; 93(5): 1443 - 1447. [Full Text] [PDF]
|
|
|
|
|
|
C. Pardoux, X. Ma, S. Gobert, S. Pellegrini, P. Mayeux, F. Gay, G. Trinchieri, and S. Chouaib Downregulation of Interleukin-12 (IL-12) Responsiveness in Human T Cells by Transforming Growth Factor-beta : Relationship With IL-12 Signaling Blood, March 1, 1999; 93(5): 1448 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Genestier, S. Kasibhatla, T. Brunner, and D. R. Green Transforming Growth Factor {beta}1 Inhibits Fas Ligand Expression and Subsequent Activation-induced Cell Death in T Cells via Downregulation of c-Myc J. Exp. Med., January 18, 1999; 189(2): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Piccirillo, Y. Chang, and G. J. Prud'homme TGF-{beta}1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice J. Immunol., October 15, 1998; 161(8): 3950 - 3956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Sengupta, E. S. Talbot, P. A. Scherle, and L. B. Ivashkiv Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases PNAS, September 15, 1998; 95(19): 11107 - 11112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bright and S. Sriram TGF-{beta} Inhibits IL-12-Induced Activation of Jak-STAT Pathway in T Lymphocytes J. Immunol., August 15, 1998; 161(4): 1772 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kulms and T. Schwarz Ultraviolet Radiation Inhibits Interleukin-2-induced Tyrosine Phosphorylation and the Activation of STAT5 in T Lymphocytes J. Biol. Chem., April 13, 2001; 276(16): 12849 - 12855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Hellstrom, J. A. Ledbetter, N. Scholler, Y. Yang, Z. Ye, G. Goodman, J. Pullman, M. Hayden-Ledbetter, and K. E. Hellstrom CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer PNAS, June 5, 2001; 98(12): 6783 - 6788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Sullivan, J. J. Letterio, A. van Elsas, M. Mamura, J. van Amelsfort, S. Sharpe, B. Metzler, C. A. Chambers, and J. P. Allison Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation PNAS, February 27, 2001; 98(5): 2587 - 2592. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
